6505--Lab - PET Radiopharmaceuticals
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Department of Veterans Affairs (VA), Network Contracting Office 2, is soliciting quotes for Positron Emission Tomography (PET) Radiopharmaceuticals for the Albany VA Medical Center in New York. This is a Full and Open competition for a five-year, Firm Fixed-Price, Indefinite Delivery, Indefinite Quantity (IDIQ) contract. Quotes are due February 11, 2026, at 3:00 PM EST.
Scope of Work
The awarded contractor will provide various PET radiopharmaceuticals, including F18 FDG Fluorodeoxyglucose, F18 NaF Sodium Fluoride, Pylarify (piflufolastat F18), Neuroceq (florbetaben F18), and Flyrcado (flurpiridaz F18) in unit doses. Deliveries are required daily by 8:00 AM or calibration time, Monday through Friday, to the Stratton VA Medical Center in Albany. The contractor must be a US Nuclear Regulatory Commission (NRC) and Food and Drug Administration (FDA) licensed radiopharmacy, authorized to manufacture and distribute these supplies in New York State, and regularly established in this business. All associated costs, including shipping, handling, packaging, storage, and licenses, must be included in quoted prices.
Contract Details
- Contract Type: Firm Fixed-Price, Indefinite Delivery, Indefinite Quantity (IDIQ)
- Period of Performance: Five years (one base year and four option years), from March 15, 2026, through March 14, 2031.
- Guaranteed Minimum: $50,000.00 between contract award and September 30, 2026.
- Set-Aside: None (Full and Open Competition)
- NAICS Code: 325412 - Pharmaceutical Preparation Manufacturing (Size Standard: 1,300 employees)
- FSC/PSC: 6505 - Drugs and Biologicals
- Place of Performance: Albany VA Medical Center, Albany, NY.
Submission & Evaluation
- Response Due: February 11, 2026, 3:00 PM EST.
- Questions Due: February 4, 2026, 3:00 PM EST.
- Submission Method: Electronic submission via email to Jonathan.kilgore@va.gov.
- Evaluation Factors: Quotes will be evaluated comparatively based on:
- Technical or Quality: Ability to meet/exceed requirements.
- Past Performance: Assessment of success likelihood.
- Veterans Involvement: Price evaluation credit for verified SDVOSBs (5%) and VOSBs (2.5%), and consideration for subcontracting with them.
- Price: Total of all line-item prices, including options.
- Key Requirements for Quote: Include copies of current NRC/FDA licenses, proof of personnel qualifications (Nuclear Pharmacists or supervised Licensed Technologists), and a statement of agreement with terms or listed exceptions. SAM.gov registration is mandatory.
Additional Notes
The Government intends to award without discussions and reserves the right to accept offers other than the lowest price if it provides additional benefits. Performance must be within the United States.